View in EDS HTML Full Text PDF Full Text

Distinct mutational pattern of myelodysplastic syndromes with and without 5q- treated with lenalidomide.

Saved in:
Bibliographic Details
Title: Distinct mutational pattern of myelodysplastic syndromes with and without 5q- treated with lenalidomide.
Authors: Adema V; MDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Palomo L; MDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain., Toma A; Assistance Publique - Hôpitaux de Paris, Service Hematologie Clinique, Hôpital Universitaire Henri Mondor, Creteil, France., Kosmider O; Assistance Publique-Hopitaux de Paris, Service d'Hematologie Biologique, Hopitaux Universitaires Paris Centre, Paris, France., Fuster-Tormo F; MDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain., Benito R; Unidad de Diagnóstico Molecular y Celular del Cáncer, IBSAL, IBMCC-Centro de Investigación del Cáncer (USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Department of Medicine, Universidad de Salamanca, Salamanca, Spain.; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain., Salgado R; Laboratorio de Citogenetica, Servicio de Hematología, Hospital Universitario fundación Jimenez Díaz, Madrid, Spain., Such E; Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Departamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Genetics Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Larrayoz MJ; Department of Genetics, School of Medicine, University of Navarra, IDISNA, Pamplona, Spain., Xicoy B; Hematology Service, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autonoma de Barcelona, Badalona, Spain., Hernandez-Sanchez JM; Unidad de Diagnóstico Molecular y Celular del Cáncer, IBSAL, IBMCC-Centro de Investigación del Cáncer (USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Department of Medicine, Universidad de Salamanca, Salamanca, Spain.; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain., Maietta P; Scientific & Innovation Department, Nimgenetics, Madrid, Spain., Neef A; Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Departamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Genetics Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Fontenay M; Assistance Publique-Hopitaux de Paris, Service d'Hematologie Biologique, Hopitaux Universitaires Paris Centre, Paris, France., Ibañez M; Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Departamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Genetics Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Diez-Campelo M; Unidad de Diagnóstico Molecular y Celular del Cáncer, IBSAL, IBMCC-Centro de Investigación del Cáncer (USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Department of Medicine, Universidad de Salamanca, Salamanca, Spain.; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain., Alvarez S; Scientific & Innovation Department, Nimgenetics, Madrid, Spain., Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Fenaux P; Assistance Publique-Hopitaux de Paris, Service d'Hematologie Biologique, Hopitaux Universitaires Paris Centre, Paris, France., Sole F; MDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.
Source: British journal of haematology [Br J Haematol] 2020 May; Vol. 189 (4), pp. e133-e137. Date of Electronic Publication: 2020 Mar 09.
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32147816
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Distinct mutational pattern of myelodysplastic syndromes with and without 5q- treated with lenalidomide.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Adema+V%22">Adema V</searchLink>; MDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Palomo+L%22">Palomo L</searchLink>; MDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Toma+A%22">Toma A</searchLink>; Assistance Publique - Hôpitaux de Paris, Service Hematologie Clinique, Hôpital Universitaire Henri Mondor, Creteil, France.<br /><searchLink fieldCode="AU" term="%22Kosmider+O%22">Kosmider O</searchLink>; Assistance Publique-Hopitaux de Paris, Service d'Hematologie Biologique, Hopitaux Universitaires Paris Centre, Paris, France.<br /><searchLink fieldCode="AU" term="%22Fuster-Tormo+F%22">Fuster-Tormo F</searchLink>; MDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Benito+R%22">Benito R</searchLink>; Unidad de Diagnóstico Molecular y Celular del Cáncer, IBSAL, IBMCC-Centro de Investigación del Cáncer (USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Department of Medicine, Universidad de Salamanca, Salamanca, Spain.; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Salgado+R%22">Salgado R</searchLink>; Laboratorio de Citogenetica, Servicio de Hematología, Hospital Universitario fundación Jimenez Díaz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Such+E%22">Such E</searchLink>; Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Departamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Genetics Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Larrayoz+MJ%22">Larrayoz MJ</searchLink>; Department of Genetics, School of Medicine, University of Navarra, IDISNA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Xicoy+B%22">Xicoy B</searchLink>; Hematology Service, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autonoma de Barcelona, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Hernandez-Sanchez+JM%22">Hernandez-Sanchez JM</searchLink>; Unidad de Diagnóstico Molecular y Celular del Cáncer, IBSAL, IBMCC-Centro de Investigación del Cáncer (USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Department of Medicine, Universidad de Salamanca, Salamanca, Spain.; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Maietta+P%22">Maietta P</searchLink>; Scientific & Innovation Department, Nimgenetics, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Neef+A%22">Neef A</searchLink>; Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Departamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Genetics Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Fontenay+M%22">Fontenay M</searchLink>; Assistance Publique-Hopitaux de Paris, Service d'Hematologie Biologique, Hopitaux Universitaires Paris Centre, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ibañez+M%22">Ibañez M</searchLink>; Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Departamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Genetics Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Diez-Campelo+M%22">Diez-Campelo M</searchLink>; Unidad de Diagnóstico Molecular y Celular del Cáncer, IBSAL, IBMCC-Centro de Investigación del Cáncer (USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Department of Medicine, Universidad de Salamanca, Salamanca, Spain.; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Alvarez+S%22">Alvarez S</searchLink>; Scientific & Innovation Department, Nimgenetics, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Maciejewski+JP%22">Maciejewski JP</searchLink>; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Fenaux+P%22">Fenaux P</searchLink>; Assistance Publique-Hopitaux de Paris, Service d'Hematologie Biologique, Hopitaux Universitaires Paris Centre, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sole+F%22">Sole F</searchLink>; MDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2020 May; Vol. 189 (4), pp. e133-e137. <i>Date of Electronic Publication: </i>2020 Mar 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32147816
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bjh.16558
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e133
    Titles:
      – TitleFull: Distinct mutational pattern of myelodysplastic syndromes with and without 5q- treated with lenalidomide.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Adema V
      – PersonEntity:
          Name:
            NameFull: Palomo L
      – PersonEntity:
          Name:
            NameFull: Toma A
      – PersonEntity:
          Name:
            NameFull: Kosmider O
      – PersonEntity:
          Name:
            NameFull: Fuster-Tormo F
      – PersonEntity:
          Name:
            NameFull: Benito R
      – PersonEntity:
          Name:
            NameFull: Salgado R
      – PersonEntity:
          Name:
            NameFull: Such E
      – PersonEntity:
          Name:
            NameFull: Larrayoz MJ
      – PersonEntity:
          Name:
            NameFull: Xicoy B
      – PersonEntity:
          Name:
            NameFull: Hernandez-Sanchez JM
      – PersonEntity:
          Name:
            NameFull: Maietta P
      – PersonEntity:
          Name:
            NameFull: Neef A
      – PersonEntity:
          Name:
            NameFull: Fontenay M
      – PersonEntity:
          Name:
            NameFull: Ibañez M
      – PersonEntity:
          Name:
            NameFull: Diez-Campelo M
      – PersonEntity:
          Name:
            NameFull: Alvarez S
      – PersonEntity:
          Name:
            NameFull: Maciejewski JP
      – PersonEntity:
          Name:
            NameFull: Fenaux P
      – PersonEntity:
          Name:
            NameFull: Sole F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2020 May
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2141
          Numbering:
            – Type: volume
              Value: 189
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: British journal of haematology
              Type: main
ResultId 1